ZAZZI MAURIZIO | Professor page

Elen, S., Bjorkman, P., Zazzi, M., Bohm, M., Bernal, E., Sonnerborg, A., et al. (2024). Low-level HIV viraemia during antiretroviral therapy: Longitudinal patterns and predictors of viral suppression. HIV MEDICINE, 25(1), 107-116 [10.1111/hiv.13541]. - view more
Armenia, D., Carioti, L., Micheli, V., Bon, I., Allice, T., Bonura, C., et al. (2024). Comparison of Different HIV-1 Resistance Interpretation Tools for Next-Generation Sequencing in Italy. VIRUSES, 16(9) [10.3390/v16091422]. - view more
Giammarino, F., de Salazar, A., Malet, I., Vinuela, L., Fuentes, A., Saladini, F., et al. (2024). Prevalence and Phenotypic Susceptibility to Doravirine of the HIV-1 Reverse Transcriptase V106I Polymorphism in B and Non-B Subtypes. THE JOURNAL OF INFECTIOUS DISEASES, 229(6), 1796-1802 [10.1093/infdis/jiae010]. - view more
Cesarini, S., Vicenti, I., Poggialini, F., Filippi, S., Mancin, E., Fiaschi, L., et al. (2024). Serendipitous identification of azine anticancer agents using a privileged scaffold morphing strategy. MOLECULES, 29(7) [10.3390/molecules29071452]. - view more
Panza, F., Saladini, F., Bartolini, N., Gianmarino, F., Montagnani, F., Spagnuolo, V., et al. (2024). PRESTIGIO RING “a 59-year-old man with multidrug resistant HIV-1 infection failing a regimen including dolutegravir, rilpivirine, atazanavir/cobicistat: successful treatment tailoring based on genotypic and phenotypic resistance tests”. NEW MICROBIOLOGICA, 47(1), 116-122. - view more